Familiarizing themselves with breast cancer risk factors empowers women to make informed decisions about screening methods, frequency, and potential preventive measures, according to Dr. Holly J. Pederson, Director of Medical Breast Services at Cleveland Clinic’s Breast Center.
With evolving breast cancer screening guidelines, understanding risk factors becomes crucial for appropriate screenings and risk reduction.
Supplementary Screening in Early Detection and Risk Management
Dr. Pederson emphasizes the importance of mammograms for understanding breast density, which can obscure findings and increase breast cancer risk. Recommending a baseline mammogram by age 40 for average-risk women, she underscores discussing breast density and risk factors with healthcare providers for a personalized screening plan.
Both average-risk and high-risk women benefit from annual mammography as long as they remain healthy. Dr. Pederson asserts that screening mammography saves lives, detecting microcalcifications, an early sign of breast cancer.
While radiation concerns are negligible, supplemental screening options like FAST mammograms may be considered for dense breasts, providing early detection despite possible false positives.
Dr. Pederson compares the yield of different supplemental screening options. For every 1,000 women screened with conventional mammograms, approximately 5 breast cancers are detected.
The supplemental yield with 3D mammograms ranges from 1.2-3 additional breast cancers, while FAST MRI detects 15.1-27.4 additional cases. Other options, such as contrast-enhanced mammography and whole-breast ultrasound, yield varying additional detections.
Read more: Get Ready For Tax Season: Important Facts About Your 2024 Tax Refund
Advancing Breast Health
Beyond breast density, non-modifiable risk factors include medical and family history, emphasizing the importance of discussions with healthcare providers. Dr. Pederson advises assessing red flags for genetic testing, considering ancestry and incidents of breast cancer, as well as other cancer types.
Genetic testing informs treatment decisions, identifies candidates for advanced screenings, risk-reducing medications, and potential surgeries in high-risk individuals.
Dr. Pederson’s guidance highlights the critical role of understanding breast cancer risk factors in navigating screenings and preventive measures. Empowering women with knowledge about mammography, breast density, and supplemental screening options allows for informed healthcare decisions.
Regular discussions with healthcare providers enable personalized screening plans, genetic testing considerations, and proactive management of breast cancer risk factors, contributing to early detection and effective prevention strategies.
Read more: CDC Raises Red Flag As Syphilis Cases Soar In Women Across The Nation
